Dr. Geschwind’s expertise in liver cancer is internationally recognized. He has been a lead or co-investigator in over 50 clinical trials aimed at developing innovative therapies, including intra-arterial therapy using radioactive microspheres and noninvasive ultrasound-guided treatment options. These therapies offer hope to patients with liver cancer, a condition often associated wit... https://www.bumc.bu.edu/camed/jean-francois-jeff-geschwind-m-d-91-2011-distinguished-alumnus-award/